Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to two new non-executive employees. The awards, granted on February 1, 2025, consist of restricted stock units covering 35,000 shares of Teladoc's common stock. The vesting schedule includes one-third of the shares on the first anniversary of the grant date, with the remaining shares vesting quarterly over the subsequent two years, contingent on continued employment. The awards were approved by the Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.
Teladoc Health (NYSE:TDOC) ha annunciato l'emissione di premi incentivanti a due nuovi dipendenti non esecutivi. I premi, concessi il 1° febbraio 2025, consistono in unità di azioni vincolate che coprono 35.000 azioni ordinarie di Teladoc. Il programma di maturazione prevede un terzo delle azioni alla prima scadenza annuale dalla data di assegnazione, con le restanti azioni che matureranno trimestralmente nei successivi due anni, soggette a un impiego continuato. I premi sono stati approvati dal Comitato per la Remunerazione ai sensi del Piano di Incentivazione per l'Assunzione del 2023 dell'azienda, in conformità con la Regola 303A.08 della NYSE.
Teladoc Health (NYSE:TDOC) ha anunciado la emisión de premios de incentivo a dos nuevos empleados no ejecutivos. Los premios, otorgados el 1 de febrero de 2025, consisten en unidades de acciones restringidas que cubren 35,000 acciones ordinarias de Teladoc. El cronograma de adquisición incluye un tercio de las acciones en el primer aniversario de la fecha de concesión, y las acciones restantes se adquirirán trimestralmente durante los dos años siguientes, sujeto a la continuidad del empleo. Los premios fueron aprobados por el Comité de Compensación bajo el Plan de Incentivos por Contratación de 2023 de la empresa, en cumplimiento con la Regla 303A.08 de la NYSE.
텔라독 헬스(Teladoc Health, NYSE:TDOC)가 두 명의 새로운 비상임 직원에게 유인 보상을 수여한다고 발표했습니다. 이 보상은 2025년 2월 1일에 부여되며, 텔라독의 보통주 35,000주를 포함하는 제한 주식 단위로 구성됩니다. 주식의 취득 일정은 부여일의 첫 번째 기념일에 1/3이 취득되고, 나머지 주식은 이후 2년 동안 분기별로 취득되며, 계속 고용되는 조건입니다. 이 보상은 2023년 고용 유인 인센티브 상금 계획에 따라 보상위원회에서 승인되었으며, NYSE 규정 303A.08을 준수합니다.
Teladoc Health (NYSE:TDOC) a annoncé l'octroi de primes d'incitation à deux nouveaux employés non exécutifs. Les primes, accordées le 1er février 2025, consistent en des unités d'actions restreintes couvrant 35 000 actions ordinaires de Teladoc. Le calendrier d'acquisition prévoit un tiers des actions à la première anniversaire de la date d'octroi, les actions restantes étant acquises trimestriellement au cours des deux années suivantes, sous réserve d'un emploi continu. Les primes ont été approuvées par le Comité de Rémunération dans le cadre du Plan d'Incentives d'Emploi 2023 de l'entreprise, conformément à la Règle 303A.08 de la NYSE.
Teladoc Health (NYSE:TDOC) hat die Vergabe von Anreizprämien an zwei neue nicht-executive Mitarbeiter bekannt gegeben. Die Prämien, die am 1. Februar 2025 vergeben wurden, bestehen aus beschränkten Aktieneinheiten, die 35.000 Aktien des Stammkapitals von Teladoc abdecken. Der Vesting-Plan sieht vor, dass ein Drittel der Aktien am ersten Jahrestag des Vergabetermins und die verbleibenden Aktien vierteljährlich in den folgenden zwei Jahren erhoben werden, abhängig von der Fortsetzung des Arbeitsverhältnisses. Die Prämien wurden vom Vergütungsausschuss im Rahmen des Unternehmensplans für Anreizvergaben 2023 genehmigt, in Übereinstimmung mit der NYSE-Regel 303A.08.
- Strategic talent acquisition supported by equity-based compensation
- Structured vesting schedule promotes long-term employee retention
- Potential dilution of existing shareholders through new stock issuance
PURCHASE, NY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to two new employees.
Effective February 1, 2025, in connection with commencing employment, two new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 35,000 shares of Teladoc Health’s common stock, par value
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
Media:
Lou Serio
202-569-9715
pr@teladochealth.com

FAQ
How many shares of TDOC stock were granted in the February 2025 inducement awards?
What is the vesting schedule for TDOC's February 2025 inducement awards?
Under which plan were TDOC's February 2025 inducement awards granted?